Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (141-150 of 400) with videos related to

Pageof 40
Sort By:
Open Forum Infectious Diseases|May 9, 2017
Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus InfectionChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Antiviral Therapy|May 28, 2005
Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis CChun-Jen Liu, Yung-Ming Jeng, Pei-Jer Chen, et al.
Hepatology (Baltimore, Md.)|November 26, 2002
Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot studyJennifer K King, Shiou-Hwei Yeh, Ming-Wei Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 19, 2016
Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis CYone-Han Mah, Chen-Hua Liu, Chi-Ling Chen, et al.
Gastroenterology|June 16, 2011
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconvertersTai-Chung Tseng, Chun-Jen Liu, Tung-Hung Su, et al.
Journal of Gastroenterology and Hepatology|March 18, 2014
Clinical presentations of patients from different age cohorts with biliary tract stone diseasesKuang-Chun Hu, Horng-Yuan Wang, Wen-Hsiung Chang, et al.
Gut and Liver|January 12, 2021
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver DiseaseShang-Chin Huang, Hau-Jyun Su, Jia-Horng Kao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 15, 2018
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world dataChun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2022
Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus InfectionChen-Hua Liu, Jou-Wei Lin, Chun-Jen Liu, et al.
Hepatology International|July 24, 2015
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patientsChing-Sheng Hsu, Shih-Jer Hsu, Hung-Chia Chen, et al.
Pageof 40

Showing results (141-150 of 400) with videos related to

Sort By:
Pageof 40
Open Forum Infectious Diseases|May 9, 2017
Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus InfectionChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Antiviral Therapy|May 28, 2005
Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis CChun-Jen Liu, Yung-Ming Jeng, Pei-Jer Chen, et al.
Hepatology (Baltimore, Md.)|November 26, 2002
Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot studyJennifer K King, Shiou-Hwei Yeh, Ming-Wei Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 19, 2016
Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis CYone-Han Mah, Chen-Hua Liu, Chi-Ling Chen, et al.
Gastroenterology|June 16, 2011
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconvertersTai-Chung Tseng, Chun-Jen Liu, Tung-Hung Su, et al.
Journal of Gastroenterology and Hepatology|March 18, 2014
Clinical presentations of patients from different age cohorts with biliary tract stone diseasesKuang-Chun Hu, Horng-Yuan Wang, Wen-Hsiung Chang, et al.
Gut and Liver|January 12, 2021
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver DiseaseShang-Chin Huang, Hau-Jyun Su, Jia-Horng Kao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 15, 2018
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world dataChun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2022
Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus InfectionChen-Hua Liu, Jou-Wei Lin, Chun-Jen Liu, et al.
Hepatology International|July 24, 2015
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patientsChing-Sheng Hsu, Shih-Jer Hsu, Hung-Chia Chen, et al.
Pageof 40